Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed London Stock Exchange - 04/17 11:35:23 am
1559 GBp   -0.29%
4h ago GLAXOSMITHKLINE : Assigned Patent
5h ago GLAXOSMITHKLINE : GSK and Genmab receive FDA approval for Arzerra (ofatumum..
1d ago GLAXOSMITHKLINE : GSK and Genmab receive FDA approval for Arzerra® (ofatumu..
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

GlaxoSmithKline And University Of Nottingham Establish Research Center

04/26/2012 | 04:46am US/Eastern
Recommend:
0

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
Recommend :
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
4h ago GLAXOSMITHKLINE : Assigned Patent
5h ago GLAXOSMITHKLINE : GSK and Genmab receive FDA approval for Arzerra (ofatumumab) a..
1d ago GLAXOSMITHKLINE : GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) ..
1d ago China's new breed of whistleblowers takes on big business
1d ago GLAXOSMITHKLINE : GSK announces approval in Canada for Incruse™ Ellipta&tr..
1d agoDJGLAXOSMITHKLINE : GSK Says Incruse Gets Approval in Canada for Treatment of Lung..
1d ago GLAXOSMITHKLINE : GSK announces approval in Canada for Incruse Ellipta (umeclidi..
1d ago GLAXOSMITHKLINE : GSK receives approval in Canada for Incruse
1d ago GLAXOSMITHKLINE : Glaxo COPD Treatment Incruse Ellipta Cleared In Canada
1d ago GSK, facing bribery claims, battles to build new sales model
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF